Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

1999 ◽  
Vol 44 (2) ◽  
pp. 159-163 ◽  
Author(s):  
Alfredo Falcone ◽  
Giacomo Allegrini ◽  
Monica Lencioni ◽  
Elisabetta Pfanner ◽  
Isa Brunetti ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Continuous Infusion ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer

1988 ◽  
Vol 24 (4) ◽  
pp. 801-802 ◽  
Author(s):  
Janke Greidanus ◽  
Pax H.B. Willemse ◽  
Dirk Th. Sleijfer ◽  
Nanno H. Mulder ◽  
RenéC.J. Verschueren ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Continuous Infusion ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Infusion Schedule

Phase II study of low dose CPT-11 administered three times weekly in fluorouracil refractory patients with metastatic colorectal cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3719-3719
Author(s):  
E. Shinozaki ◽  
N. Mizunuma ◽  
E. Nagasaki ◽  
N. Horikoshi ◽  
T. Muto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study

Phase II study of low dose CPT-11 administered three times weekly in fluorouracil refractory patients with metastatic colorectal cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3719-3719
Author(s):  
E. Shinozaki ◽  
N. Mizunuma ◽  
E. Nagasaki ◽  
N. Horikoshi ◽  
T. Muto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study

A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

2014 ◽  
Vol 37 (1) ◽  
pp. 19-23 ◽  
Author(s):  
Yong Sang Hong ◽  
Sung Sook Lee ◽  
Kyu-pyo Kim ◽  
Jae-Lyun Lee ◽  
Yoon-Koo Kang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

2008 ◽  
Vol 7 (4) ◽  
pp. 273-279 ◽  
Author(s):  
Teresa Gamucci ◽  
Fabrizio Nelli ◽  
Giovanni Cianci ◽  
Giulia Grassi ◽  
Luca Moscetti ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Predictive Value ◽  
Phase Ii Study ◽  
Heavily Pretreated
Sign in / Sign up

Export Citation Format

Share Document